Novartis AG-RegNVSEF
13F holders, Q2 2024 (June 30)3holders
1new positions
1sold out
$107.01avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Novartis AG-Reg (NVSEF) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were Boston Common Asset Management, LLC ($18.3M), Kennedy Capital Management LLC ($10.0M) and Partners Capital Investment Group, LLP ($4.9M).
- Company
- Novartis AG-Reg
- CUSIP
- H5820Q150
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4.9M |
| Exits | 1 | $135K |
All 13F filers, Q1 2024 → Q2 2024: 117,997 shares bought and 1,391 shares sold, net +116,606 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Boston Common Asset Management, LLC | 0.47% | Add +36.6% | 170,871 | $18.3M |
| Kennedy Capital Management LLC | 0.21% | Add +39.9% | 93,794 | $10.0M |
| Partners Capital Investment Group, LLP | 0.08% | New | 45,436 | $4.9M |
"% of holder's portfolio" is NVSEF's weight in each manager's 13F, not the share of Novartis AG-Reg the manager owns.